$24.040
-2.024 (-8.42%)At close
SPTX Comparative Benchmarking
In the context of the broader market, SPTX competes directly with industry leaders such as MLTX and MNKD. With a market capitalization of $1.29B, it holds a significant position in the sector. When comparing efficiency, SPTX's gross margin of N/A stands against MLTX's N/A and MNKD's 69.00%. Such benchmarking helps identify whether Seaport Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Seaport Therapeutics Inc Financial Performance
The company has a current ratio of 18.00, indicating strong liquidity, and total equity increased significantly to $422.6 million in Q2 2026, showing improved financial health.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.